Cargando…
Engineered red blood cells (activating antigen carriers) drive potent T cell responses and tumor regression in mice
Activation of T cell responses is essential for effective tumor clearance; however, inducing targeted, potent antigen presentation to stimulate T cell responses remains challenging. We generated Activating Antigen Carriers (AACs) by engineering red blood cells (RBCs) to encapsulate relevant tumor an...
Autores principales: | Blagovic, Katarina, Smith, Carolyne K., Ramakrishnan, Amritha, Moore, Lindsay, Soto, David R., Thompson, Zachary, Stockmann, Adam P., Kruszelnicki, Sonia, Thakkar, Akshi, Murray, Jason, Torres, Sebastian, Wondimagegnhu, Bersabel, Yi, Roslyn, Dadgar, Maisam, Paracha, Abdul M., Page, Claire, Clear, Louise, Chaudhry, Omer A., Myint, Melissa, Bridgen, Devin T., Gilbert, Jonathan B., Seidl, Katherine J., Sharei, Armon, Loughhead, Scott, Bernstein, Howard, Yarar, Defne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573954/ https://www.ncbi.nlm.nih.gov/pubmed/36263022 http://dx.doi.org/10.3389/fimmu.2022.1015585 |
Ejemplares similares
-
Cell engineering with microfluidic squeezing preserves functionality of primary immune cells in vivo
por: DiTommaso, Tia, et al.
Publicado: (2018) -
Cell Squeeze: driving more effective CD8 T-cell activation through cytosolic antigen delivery
por: Park, J.C., et al.
Publicado: (2022) -
High-throughput Nuclear Delivery and Rapid Expression of DNA via Mechanical and Electrical Cell-Membrane Disruption
por: Ding, Xiaoyun, et al.
Publicado: (2017) -
Engineered RBCs Encapsulating Antigen Induce Multi-Modal Antigen-Specific Tolerance and Protect Against Type 1 Diabetes
por: Raposo, Colin J., et al.
Publicado: (2022) -
Differential Requirements for Clathrin-dependent Endocytosis at Sites of Cell–Substrate Adhesion
por: Batchelder, Erika M., et al.
Publicado: (2010)